Injectable fillers and neuromodulators are used for a range of indications pertaining to the correction of facial aging and disfigurement. Fillers can correct soft tissue loss, depressed scars, and atrophy or asymmetry induced by systemic or local disease
PLLA-induced augmentation is most likely based on capsule formation orchestrating macrophages, (myo-)fibroblasts, and collagen type I and III fibres. We observed considerably slower degradation of PLLA particles than described previously. Thus PLLA partic
The approach to soft tissue augmentation has evolved dramatically in recent years. With a greater appreciation for changes in facial soft tissue contours that occur with age has come an expansion of the role for fillers in rejuvenation of the midface. Ove